Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06657248, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Aesculap AG
- Trial code
- NCT06657248
- Record updated
- 16 October 2026
- Original description
The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.Read full original descriptionShow less
Prospective, Multicenter Study Evaluating the Midterm Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Knee Implant
The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.
Inclusion: Indication for a primary medial unicompartmental knee endoprosthesis; Acc. to Instructions for Use:; Both cruciate ligaments intact; Lateral ligaments intact; Leg axis amenable to passive correction; Varus deformity under 15°; Bending capability of at least 90°; Extension deficit no greater than 5-10°; Written informed consent of patient; Kellgran \& Lawrence Score > II (only straight or varus; Patients with moderate radiological symptoms; Patients without clinical symptoms.
Exclusion: Patient age <18 and > 75 years; Pregnancy; BMI ≥ 40; High risk patients ASA > III.